March 12th 2024, 10:08pm
An expert explained that patients with breast cancer who undergo genetic testing may help their family members, regardless of whether patients have children.
March 12th 2024, 9:00pm
At the Miami Breast Cancer Conference and Educated Patient Breast Cancer Summit, an expert explained HER2-positive breast cancer and gave an overview of effective treatment options in this space.
March 8th 2024, 10:00pm
An expert gives an overview of common endocrine-related side effects that premenopausal women with breast cancer may experience — and what can be done to address them.
April 5th 2023, 9:00pm
When a green dye was used to detect early signs of breast cancer-related lymphedema, patients tended to have better outcomes with the condition, recent research showed.
HER3-DXd proved to be safe and efficacious in treating patients with HER3-expressing metastatic breast cancer, recent study results showed.
March 30th 2023, 3:00pm
The current testing rate for BRCA 1/2 mutations is currently 68% in HER2-negative early breast cancer, but eligible patients could receive better care if tested.
March 4th 2022, 10:00pm
From the use of anti-depressants to cryotherapy, researchers continue to explore potential ways to mitigate the side effects that are associated with breast cancer therapy.
March 28th 2020, 1:00am
“Often you think we’re the victim, but there’s a lot that you can do to be your own advocate and participate in your healing,” says stage four metastatic breast cancer thriver Nalie Agustin.
March 24th 2020, 7:06pm
Genetic testing offers a care team a wealth of knowledge to help them craft treatments, but it also can help match patients to clinical trials for potentially better outcomes.
March 24th 2020, 12:15am
Patients faced with cancer are also faced with tough uphill financial battles, but there are assistance programs that can help.
Should I Quit My Day Job While Living With Cancer?
How Q-TWiST Can Guide Kidney Cancer Treatment Choices
Metastasis-Directed Radiotherapy Shows Improved Kidney Cancer Outcomes
Zusduri Shows Durable Responses in Some Bladder Cancers